FULC Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $3.69

Capitalizzazione di Mercato (MRQ) $281M

P/E -3.1

EPS $-1.18

Ricavi $0

ROE -26.6%

Intervallo 52 sett. $3–$16

FULC Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Fulcrum Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaPharmaceuticals dipendenti9 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$0

2020-12-31 → 2025-12-31

EPS$-1.18

2020-12-31 → 2025-12-31

Flusso di cassa libero$-60M

2019-12-31 → 2025-12-31

Margine netto·

2020-12-31 → 2024-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	FULC	media 5 anni	Mediana dei peer	Verdetto
P/E	-3.1media 5 anni ≈-10.8	≈-10.8	·	·
P/B (MRQ)	0.9media 5 anni ≈1.7	≈1.7	2.3	Sottovalutato
Prezzo / FCF (TTM)	-4.3media 5 anni ≈-30.6	≈-30.6	·	·
Prezzo / Flusso di cassa (TTM)	-4.3media 5 anni ≈-33.8	≈-33.8	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	0.7media 5 anni ≈2.1	≈2.1	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	Tendenza 5 anni	FULC	media 5 anni	Mediana dei peer	Verdetto
ROA		-23.9%media 5 anni ≈-28.9%	≈-28.9%	-34.8%	Di prim'ordine
ROE		-26.6%media 5 anni ≈-30.6%	≈-30.6%	-42.1%	Di prim'ordine

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	FULC	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		31.4media 5 anni ≈20.0	≈20.0	9.4	Liquidità elevata
Quick Ratio		15.1media 5 anni ≈6.1	≈6.1	4.5	In linea

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	Tendenza 5 anni	FULC	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)		2752.0%media 5 anni ≈686.6%	≈686.6%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)		61.0%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	FULC	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-1.18media 5 anni ≈$-1.53	≈$-1.53	·	·
Revenue / Share (Ricavi / Azione)	$0.00media 5 anni ≈$369.34	≈$369.34	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-948.07media 5 anni ≈$-1156.16	≈$-1156.16	·	·
Cash / Share (Liquidità / Azione)	$2.97media 5 anni ≈$1.28	≈$1.28	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	Tendenza 5 anni	FULC	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)		0.0media 5 anni ≈0.1	≈0.1	0.2	Debole
Revenue / Employee (Ricavi / Dipendente)		≈$0.00	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 5.0%

Prossimo report Ott 27, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Lug 27, 2026	$-0.22	$-0.22	2.0%
31 Marzo 2026		$-0.25	$-0.30	17.8%
31 Dicembre 2025		$-0.31	$-0.32	1.7%
30 Settembre 2025		$-0.31	$-0.30	-3.5%
30 Giugno 2025		$-0.28	$-0.30	5.3%
31 Marzo 2025		$-0.28	$-0.30	6.6%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 12

Metrica	2025	2024	2023	2022	2021	2020
Revenue	$0	$80M	$3M	$6M	$19M	$9M
R&D Expense	$56M	$63M	$72M	$77M	$70M	$59M
SG&A Expense	$29M	$36M	$42M	$42M	$31M	$21M
Operating Expenses	$85M	$102M	$113M	$119M	$100M	$80M
Operating Income	$-85M	$-22M	$-111M	$-113M	$-81M	$-72M
Income Tax	$0	$0	·	·	·	·
Net Income	$-75M	$-10M	$-97M	$-110M	$-81M	$-71M
EPS (Basic)	$-1.18	$-0.16	$-1.59	$-2.44	$-2.29	$-2.79
EPS (Diluted)	$-1.18	$-0.16	$-1.59	$-2.44	$-2.29	$-2.79
Shares (Basic)	63,355	61,984	61,310	44,991	35,361	25,354
Shares (Diluted)	63,355	61,984	61,310	44,991	35,361	25,354
EBITDA	$-85M	$-22M	$-111M	$-113M	·	$-72M

Stato Patrimoniale 21

Metrica	2025	2024	2023	2022	2021	2020
Cash & Equivalents	$198M	$58M	$26M	$35M	$35M	$57M
Prepaid Expense	$5M	$7M	$5M	$4M	$4M	$4M
Other Current Assets	·	·	·	·	$0	$74.0K
Current Assets	$357M	$250M	$242M	$208M	$226M	$120M
PP&E (Net)	$3M	$4M	$5M	$7M	$7M	$8M
PP&E (Gross)	$18M	$18M	$18M	$18M	$16M	$15M
Accum. Depreciation	$16M	$14M	$13M	$11M	$8M	$6M
Other Non-current Assets	$538.0K	$10.0K	$2M	$2M	$542.0K	$578.0K
Total Assets	$366M	$261M	$258M	$227M	$235M	$130M
Accounts Payable	$2M	$1M	$3M	$4M	$5M	$4M
Current Liabilities	$13M	$11M	$14M	$17M	$19M	$27M
Capital Leases	$4M	$6M	$9M	$11M	$0	·
Other Non-current Liabilities	$197.0K	$197.0K	$197.0K	$197.0K	$0	·
Total Liabilities	$17M	$18M	$23M	$28M	$23M	$34M
Common Stock	$67.0K	$54.0K	$62.0K	$52.0K	$41.0K	$28.0K
Retained Earnings	$-594M	$-519M	$-510M	$-412M	$-302M	$-222M
Treasury Stock	·	·	·	$0	$0	·
AOCI	$174.0K	$130.0K	$-136.0K	$-797.0K	$-397.0K	$-2.0K
Stockholders' Equity	$349M	$243M	$235M	$199M	$212M	$95M
Liabilities + Equity	$366M	$261M	$258M	$227M	$235M	$130M
Shares Outstanding	66,578,891	53,968,303	61,915,367	52,099,211	40,626,224	27,941,566

Flusso di cassa 10

Metrica	2025	2024	2023	2022	2021	2020
Stock-based Comp	$12M	$15M	$15M	$13M	$11M	$7M
Restructuring	$400.0K	$2M	·	$400.0K	·	·
Operating Cash Flow	$-60M	$-2M	$-91M	$-97M	$-78M	$-54M
CapEx	$314.0K	$278.0K	$508.0K	$2M	$2M	$1M
Investing Cash Flow	$31M	$32M	$-37M	$12M	$-130M	$-57M
Stock Issued	$4M	$3M	$777.0K	$4M	$4M	$1M
Net Stock Activity	$4M	$3M	$777.0K	$4M	·	$1M
Financing Cash Flow	$169M	$3M	$118M	$84M	$187M	$71M
Net Change in Cash	$139M	$33M	$-10M	$-314.0K	$-22M	$-40M
Free Cash Flow	$-60M	$-2M	$-91M	$-99M	·	$-55M

Redditività 5

Metrica	2025	2024	2023	2022	2021	2020
Operating Margin	·	-27.4%	-3945.2%	-1774.8%	·	-811.6%
Net Margin	·	-12.2%	-3470.0%	-1732.4%	·	-802.7%
EBITDA Margin	·	-27.4%	-3945.2%	-1774.8%	·	-811.6%
ROA	-23.9%	-3.8%	-40.2%	-47.6%	·	-59.0%
ROE	-26.6%	-3.9%	-39.7%	-52.3%	·	-70.8%

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020
Current Ratio		27.4	22.6	17.7	12.4	·	4.5
Quick Ratio		15.1	5.3	1.9	2.1	·	2.1

Efficienza 1

Metrica	Tendenza	2025	2024	2023	2022	2021	2020
Asset Turnover		0.0	0.3	0.0	0.0	·	0.1

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020
Book Value / Share	$5.24	$4.50	$3.80	$3.82	·	$3.41
Revenue / Share	$0.00	$1290.66	$45.75	$140.96	·	·
Cash Flow / Share	$-948.07	$-35.78	$-1483.69	$-2157.10	·	·
Cash / Share	$2.97	$1.08	$0.41	$0.67	·	$2.04
EPS (TTM)	$-1.18	$-0.16	$-1.59	$-2.44	$-2.29	$-2.79

Tassi di Crescita 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020
Revenue YoY		·	2752.0%	-55.8%	-66.9%	117.2%	·
Revenue CAGR 3Y		·	61.0%	-31.8%	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020
Revenue TTM	$0	$80M	$3M	$6M	$19M	$9M
Net Income TTM	$-75M	$-10M	$-97M	$-110M	$-81M	$-71M
Market Cap	$753M	$254M	$418M	$379M	·	$327M
P/E	-9.6	-29.4	-4.2	-3.0	-7.7	-4.2
P/S	·	3.2	149.0	59.8	·	37.1
P/B	2.2	1.0	1.8	1.9	·	3.4
P / Tangible Book	2.2	1.0	1.8	1.9	3.4	3.4
P / Cash Flow	-12.5	-114.4	-4.6	-3.9	·	-6.1
P / FCF	-12.5	-101.6	-4.6	-3.8	·	-5.9
Earnings Yield	-10.4%	-3.4%	-23.6%	-33.5%	-13.0%	-23.8%

Conto Economico 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	·	·	$0	$0	$0	·	$0	$0	$80M	$0	$871.0K	$759.0K	$880.0K	$295.0K	$685.0K	$1M
R&D Expense	$12M	$14M	$15M	$14M	$13M	$13M	$12M	$15M	$17M	$20M	$19M	$18M	$18M	$17M	$19M	$15M
SG&A Expense	$7M	$8M	$7M	$8M	$7M	$7M	$8M	$8M	$10M	$10M	$10M	$10M	$10M	$12M	$10M	$10M
Operating Expenses	$29M	$22M	$23M	$22M	$20M	$20M	$19M	$25M	$28M	$30M	$29M	$28M	$28M	$28M	$29M	$26M
Operating Income	$-29M	$-22M	$-23M	$-22M	$-20M	$-20M	$-19M	$-25M	$52M	$-30M	$-28M	$-27M	$-27M	$-28M	$-28M	$-24M
Net Income	$-26M	$-19M	$-20M	$-20M	$-17M	$-18M	$-17M	$-22M	$55M	$-27M	$-25M	$-24M	$-24M	$-25M	$-26M	$-24M
EPS (Basic)	$-0.34	$-0.25	$-0.31	$-0.31	$-0.28	$-0.28	$-0.27	$-0.35	$0.89	$-0.43	$-0.41	$-0.39	$-0.38	$-0.41	$-0.46	$-0.51
EPS (Diluted)	$-0.34	$-0.25	$-0.31	$-0.31	$-0.28	$-0.28	$-0.25	$-0.35	$0.87	$-0.43	$-0.41	$-0.39	$-0.38	$-0.41	$-0.46	$-0.51
Shares (Basic)	76,264,000	76,215,000	·	62,597,000	62,544,000	62,479,000	·	62,409,000	62,205,000	61,984,000	·	61,823,000	61,794,000	59,722	·	46,213
Shares (Diluted)	76,264,000	76,215,000	·	62,597,000	62,544,000	62,479,000	·	62,409,000	63,587,000	61,984,000	·	61,823,000	61,794,000	59,722	·	46,213
EBITDA	$-29M	$-22M	·	$-22M	$-20M	$-20M	·	$-25M	$52M	$-30M	·	$-27M	$-27M	$-28M	·	$-24M

Stato Patrimoniale 21

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$48M	$50M	$198M	$47M	$43M	$42M	$58M	$73M	$87M	$40M	$26M	$30M	$34M	$35M	$35M	$91M
Prepaid Expense	$4M	$5M	$5M	$5M	$5M	$5M	$7M	$7M	$4M	$5M	$5M	$5M	$4M	$5M	$4M	$5M
Other Current Assets	·	·	·	·	$69.0K	·	·	·	·	·	·	·	·	·	·	·
Current Assets	$323M	$339M	$357M	$206M	$219M	$233M	$250M	$267M	$280M	$218M	$242M	$262M	$283M	$303M	$208M	$228M
PP&E (Net)	$0	$2M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$5M	$5M	$6M	$6M	$7M	$7M	$7M
PP&E (Gross)	$1M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$17M
Accum. Depreciation	$1M	$15M	$16M	$15M	$15M	$15M	$14M	$14M	$14M	$13M	$13M	$12M	$12M	$11M	$11M	$10M
Other Non-current Assets	$9.0K	$546.0K	$538.0K	$9.0K	$12.0K	$10.0K	$10.0K	$76.0K	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Total Assets	$324M	$347M	$366M	$215M	$229M	$243M	$261M	$279M	$294M	$233M	$258M	$279M	$300M	$321M	$227M	$248M
Accounts Payable	$3M	$2M	$2M	$3M	$2M	$2M	$1M	$4M	$4M	$4M	$3M	$4M	$4M	$4M	$4M	$3M
Current Liabilities	$10M	$10M	$13M	$12M	$9M	$8M	$11M	$15M	$13M	$11M	$14M	$14M	$15M	$14M	$17M	$15M
Capital Leases	$3M	$3M	$4M	$5M	$5M	$6M	$6M	$7M	$8M	$8M	$9M	$9M	$10M	$10M	$11M	$11M
Other Non-current Liabilities	$197.0K	$197.0K	$197.0K	$197.0K	$197.0K	$197.0K	$197.0K	$197.0K	$197.0K	$197.0K	$197.0K	$197.0K	$447.0K	$320.0K	$197.0K	$197.0K
Total Liabilities	$13M	$13M	$17M	$16M	$14M	$14M	$18M	$22M	$20M	$19M	$23M	$23M	$25M	$25M	$28M	$26M
Common Stock	$76.0K	$67.0K	$67.0K	$54.0K	$54.0K	$54.0K	$54.0K	$54.0K	$62.0K	$62.0K	$62.0K	$62.0K	$62.0K	$62.0K	$52.0K	$52.0K
Retained Earnings	$-639M	$-613M	$-594M	$-574M	$-554M	$-537M	$-519M	$-503M	$-481M	$-537M	$-510M	$-485M	$-461M	$-437M	$-412M	$-386M
Treasury Stock	·	·	·	·	·	·	·	·	·	·	·	·	$0	$0	·	$0
AOCI	$-567.0K	$-513.0K	$174.0K	$241.0K	$82.0K	$70.0K	$130.0K	$379.0K	$-366.0K	$-434.0K	$-136.0K	$-886.0K	$-1M	$-651.0K	$-797.0K	$-921.0K
Stockholders' Equity	$311M	$333M	$349M	$198M	$214M	$228M	$243M	$257M	$274M	$214M	$235M	$255M	$275M	$296M	$199M	$221M
Liabilities + Equity	$324M	$347M	$366M	$215M	$229M	$243M	$261M	$279M	$294M	$233M	$258M	$279M	$300M	$321M	$227M	$248M
Shares Outstanding	76,285,157	66,608,096	66,578,891	54,108,438	54,091,588	53,979,306	53,968,303	53,938,661	62,250,631	62,141,011	61,915,367	52,099,211	52,099,211	61,758,994	52,099,211	52,049,913

Flusso di cassa 10

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$3M	$4M	$3M	$3M	$3M	$3M	$2M	$4M	$4M	$4M	$3M	$4M	$3M	$4M	$3M	$3M
Restructuring	$4M	·	$400.0K	$0	$0	$0	$2M	$0	·	·	·	·	·	·	·	$400.0K
Operating Cash Flow	$-16M	$-19M	$-17M	$-14M	$-14M	$-15M	$-17M	$-19M	$59M	$-25M	$-23M	$-23M	$-21M	$-24M	$-20M	$-28M
CapEx	$108.0K	$8.0K	$159.0K	$90.0K	$65.0K	$0	$231.0K	$19.0K	$0	$28.0K	$77.0K	$65.0K	$195.0K	$171.0K	$116.0K	$283.0K
Investing Cash Flow	$14M	$-128M	$-1M	$19M	$14M	$-777.0K	$2M	$4M	$-13M	$38M	$18M	$19M	$20M	$-94M	$-36M	$-2M
Stock Issued	$356.0K	$21.0K	$4M	$64.0K	$301.0K	$0	$83.0K	$635.0K	$377.0K	$2M	$287.0K	$0	$142.0K	$348.0K	$267.0K	$93.0K
Net Stock Activity	·	$21.0K	·	·	·	$0	·	·	·	$2M	·	·	·	$348.0K	·	·
Financing Cash Flow	$356.0K	$-312.0K	$168M	$64.0K	$301.0K	$0	$83.0K	$635.0K	$377.0K	$2M	$287.0K	$0	$142.0K	$118M	$218.0K	$81M
Net Change in Cash	$-2M	$-147M	$150M	$4M	$414.0K	$-16M	$-14M	$-14M	$47M	$14M	$-5M	$-4M	$-768.0K	$-364.0K	$-56M	$51M
Free Cash Flow	·	$-19M	·	·	·	$-15M	·	·	·	$-25M	·	·	·	$-24M	·	·

Redditività 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	·	·	·	·	·	·	·	·	65.6%	·	·	-3615.3%	-3101.4%	-9471.2%	·	·
Net Margin	·	·	·	·	·	·	·	·	69.3%	·	·	-3164.3%	-2702.6%	-8399.7%	·	·
EBITDA Margin	·	·	·	·	·	·	·	·	65.6%	·	·	-3615.3%	-3101.4%	-9471.2%	·	·
ROA	-9.5%	-6.4%	·	-7.9%	-6.6%	-7.4%	·	-7.8%	22.6%	-10.1%	·	-9.1%	·	-9.2%	·	-9.4%
ROE	-10.0%	-6.7%	·	-8.6%	-7.1%	-8.0%	·	-8.5%	25.5%	-11.0%	·	-10.1%	·	-10.2%	·	-10.5%

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		31.4	34.3	·	17.7	24.4	28.7	·	18.4	22.1	20.4	·	18.6	·	21.0	·	15.5
Quick Ratio		4.7	5.1	·	4.0	4.7	5.2	·	5.0	6.8	3.7	·	2.1	·	2.4	·	6.2

Efficienza 1

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		·	·	·	0.0	0.0	·	·	0.0	0.3	0.0	·	0.0	·	0.0	·	·

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$4.07	$5.00	·	$3.67	$3.96	$4.23	·	$4.77	$4.40	$3.44	·	$4.90	·	$4.80	·	$4.25
Revenue / Share	·	·	·	$0.00	$0.00	·	·	$0.00	$1.26	$0.00	·	$12.28	$14.24	$4.94	·	·
Cash Flow / Share	·	$-0.25	·	·	·	$-0.24	·	·	·	$-407.91	·	·	·	$-403.80	·	·
Cash / Share	$0.64	$0.75	·	$0.87	$0.79	$0.78	·	$1.35	$1.39	$0.64	·	$0.58	·	$0.56	·	$1.75
EPS (TTM)	$-1.21	$-1.15	·	$-1.12	$-1.16	$-0.01	·	$-0.32	$-0.36	$-1.61	·	$-1.64	$-1.76	$-2.21	·	$-2.56

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	·	·	·	·	·	$80M	·	$81M	$82M	$3M	·	$3M	$3M	$4M	·	$11M
Net Income TTM	$-85M	$-76M	·	$-71M	$-73M	$-510.0K	·	$-18M	$-20M	$-99M	·	$-99M	$-98M	$-109M	·	$-107M
Market Cap	$279M	$511M	·	$498M	$372M	$155M	·	$193M	$386M	$587M	·	$231M	·	$176M	·	$421M
P/E	-3.0	-6.7	·	-8.2	-5.9	-288.0	·	-11.2	-17.2	-5.9	·	-2.7	-1.9	-1.3	·	-3.2
P/S	·	·	·	·	·	1.9	·	2.4	4.7	233.7	·	88.3	·	43.5	·	39.3
P/B	0.9	1.5	·	2.5	1.7	0.7	·	0.7	1.4	2.7	·	0.9	·	0.6	·	1.9
P / Tangible Book	0.9	1.5	·	2.5	1.7	0.7	·	0.7	1.4	2.7	·	0.9	·	0.6	·	1.9
P / Cash Flow	·	-27.2	·	·	·	-10.2	·	·	·	-23.2	·	·	·	-7.3	·	·
Earnings Yield	-33.1%	-15.0%	·	-12.2%	-16.9%	-0.35%	·	-9.0%	-5.8%	-17.1%	·	-36.9%	-53.3%	-77.5%	·	-31.6%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$0	$80M	$3M	$6M	$19M
Margine Operativo %	·	-27.4%	-3945.2%	-1774.8%	·
Utile netto	$-75M	$-10M	$-97M	$-110M	$-81M
EPS Diluito	$-1.18	$-0.16	$-1.59	$-2.44	$-2.29

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	27.4	22.6	17.7	12.4	·
Quick Ratio	15.1	5.3	1.9	2.1	·

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-60M	$-2M	$-91M	$-99M	·

Proprietari istituzionali (13F) 167 filer · $328.0M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 167

Valore detenuto $328.0M

Nuove posizioni 30

Posizioni chiuse 40

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
30 (-8 vs trimestre precedente)	40 (+4 vs trimestre precedente)	75 (0 vs trimestre precedente)	35 (-4 vs trimestre precedente)	+7.5M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
VANGUARD GROUP INC	$40.258.533	3.559.552	12,28%	Azioni
BlackRock, Inc.	$32.296.788	8.824.259	9,85%	Azioni
EcoR1 Capital, LLC	$23.972.510	6.549.866	7,31%	Azioni
TANG CAPITAL MANAGEMENT LLC	$23.868.368	6.521.412	7,28%	Azioni
Nantahala Capital Management, LLC	$20.038.646	5.475.040	6,11%	Azioni
MONTANOVA CAPITAL, LLC	$13.472.171	3.680.921	4,11%	Azioni
D. E. Shaw & Co., Inc.	$11.142.449	3.044.385	3,40%	Azioni
CITADEL ADVISORS LLC	$9.898.488	2.704.505	3,02%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$9.871.811	2.697.216	3,01%	Azioni
JANE STREET GROUP, LLC	$8.116.043	2.217.498	2,47%	Azioni
STATE STREET CORP	$7.455.512	2.037.025	2,27%	Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C.	$7.320.000	2.000.000	2,23%	Azioni
GSK plc	$6.535.713	1.785.714	1,99%	Azioni
Qube Research & Technologies Ltd	$6.399.389	1.748.467	1,95%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$6.030.948	1.647.800	1,84%	Azioni
ADAR1 Capital Management, LLC	$5.728.006	1.565.029	1,75%	Azioni
MILLENNIUM MANAGEMENT LLC	$5.438.039	1.485.803	1,66%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$5.242.680	1.432.133	1,60%	Azioni
MARSHALL WACE, LLP	$4.971.828	1.358.423	1,52%	Azioni
UBS Group AG	$4.589.307	1.253.909	1,40%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$4.322.262	1.180.946	1,32%	Azioni
AQR CAPITAL MANAGEMENT LLC	$4.037.935	1.103.261	1,23%	Azioni
GOLDMAN SACHS GROUP INC	$4.005.595	1.094.425	1,22%	Azioni
Ikarian Capital, LLC	$3.839.929	1.049.161	1,17%	Azioni
BANK OF AMERICA CORP /DE/	$3.817.486	1.043.029	1,16%	Azioni
Jump Financial, LLC	$3.678.300	1.005.000	1,12%	Azioni
DIMENSIONAL FUND ADVISORS LP	$3.515.976	960.547	1,07%	Azioni
Assenagon Asset Management S.A.	$3.056.847	835.204	0,93%	Azioni
TWO SIGMA INVESTMENTS, LP	$2.974.724	812.766	0,91%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$2.862.647	782.144	0,87%	Azioni
Connor, Clark & Lunn Investment Management Ltd.	$2.727.860	745.317	0,83%	Azioni
Balyasny Asset Management L.P.	$2.534.082	692.372	0,77%	Azioni
Y-Intercept (Hong Kong) Ltd	$2.495.505	681.832	0,76%	Azioni
Point72 Asset Management, L.P.	$2.384.223	651.427	0,73%	Azioni
NORTHERN TRUST CORP	$1.785.600	487.869	0,54%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$1.585.585	433.220	0,48%	Azioni
VANGUARD FIDUCIARY TRUST CO	$1.265.072	345.648	0,39%	Azioni
BOOTHBAY FUND MANAGEMENT, LLC	$1.112.596	303.988	0,34%	Azioni
Peapod Lane Capital LLC	$1.046.021	285.798	0,32%	Azioni
WELLINGTON MANAGEMENT GROUP LLP	$1.043.408	285.084	0,32%	Azioni
Engineers Gate Manager LP	$885.720	242.000	0,27%	Azioni
EntryPoint Capital, LLC	$794.948	217.199	0,24%	Azioni
XTX Topco Ltd	$765.844	209.247	0,23%	Azioni
CITADEL ADVISORS LLC	$743.712	203.200	0,23%	Opzione Put
Quadrature Capital Ltd	$692.176	189.119	0,21%	Azioni
MORGAN STANLEY	$674.143	184.192	0,21%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$641.964	175.400	0,20%	Opzione Put
ALLIANCEBERNSTEIN L.P.	$639.448	83.370	0,19%	Azioni
AMERICAN CENTURY COMPANIES INC	$570.477	155.868	0,17%	Azioni
Nuveen, LLC	$566.828	154.871	0,17%	Azioni

Mostra tutti i 167 proprietari istituzionali →

Insider aziendali 29 insider · 13 dirigenti · 13 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Alex Sapir	President & Chief Executive Officer	02 Febbraio 2026 A	193.360	0	$0
Bryan Stuart	President & Chief Executive Officer	19 Gennaio 2022 A	0	0	$0
Esther Rajavelu	Chief Financial Officer	09 Febbraio 2023 A	·	0	$0
Judith Dunn	President, Research & Development	19 Gennaio 2022 A	·	0	$0
Melvin H. Hayes III	Chief Operating Officer	26 Aprile 2023 A	·	0	$0
Greg Tourangeau	Principal Accounting Officer	02 Febbraio 2026 A	14.062	0	$0
Curtis Gale Oltmans	Chief Legal Officer	02 Febbraio 2026 A	10.252	1	$-44.600
Patrick Taylor Horn	Chief Medical Officer	18 Marzo 2024 A	·	0	$0
Santiago Arroyo	Chief Medical Officer	07 Novembre 2022 A	·	0	$0
Christopher Morabito	Chief Medical Officer	19 Gennaio 2022 A	1.100	0	$0
Christopher Moxham	Chief Scientific Officer	10 Agosto 2021 M	0	0	$0
Owen B. Wallace	Chief Scientific Officer	14 Settembre 2020 M	133.438	0	$0
Diego Cadavid	SVP Clinical Development	01 Luglio 2020 S	65.714	0	$0
Sonja Banks	Direttore	30 Giugno 2026 A	·	0	$0
Alan Ezekowitz	Direttore	30 Giugno 2026 A	10.927	1	$-65.700
Colin Hill	Direttore	30 Giugno 2026 A	·	0	$0
Kate Haviland	Direttore	30 Giugno 2026 A	·	0	$0
Katina Dorton	Direttore	30 Giugno 2026 A	·	0	$0
Rachel K. King	Direttore	30 Giugno 2026 A	·	0	$0
Robert J Gould	Direttore	30 Giugno 2026 A	469.864	4	$-667.350
James A Geraghty	Direttore	30 Giugno 2026 A	90.714	0	$0
Joshua Lehrer-Graiwer	Direttore	23 Aprile 2026 A	·	0	$0
James J. Collins	Direttore	17 Giugno 2024 A	·	0	$0
Mark J Levin	Direttore	10 Novembre 2021 J	3.962.202	0	$0
6 Dimensions Capital, L.P.	Proprietario del 10%	22 Luglio 2019 C	559.821	0	$0
GSK plc	Proprietario del 10%	22 Luglio 2019 C	1.785.714	0	$0
Sanofi	Proprietario del 10%	22 Luglio 2019 C	558.035	0	$0
Alan A Musso	·	02 Febbraio 2026 A	·	0	$0
Peter G. Thomson	·	19 Gennaio 2022 A	2.300	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 20 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
PILL · Direxion Shares ETF Trust	0,50%	29.016 NS	31 Luglio 2026	N-PORT
IWC · iShares Trust	0,05%	202.049 SH	10 Settembre 2026	Giornaliero
IBB · iShares Trust	0,02%	555.962 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,02%	5.408 SH	02 Ottobre 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,01%	103.543 SH	02 Ottobre 2026	Giornaliero
VFMO · VANGUARD WELLINGTON FUND	0,01%	53.282 SH	19 Agosto 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	341.378 SH	19 Agosto 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,01%	50.849 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,01%	1.524.331 SH	11 Settembre 2026	Giornaliero
RSSL · Global X Funds	0,01%	28.359 NS	31 Luglio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	54.992 NS	31 Luglio 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	93.958 NS	31 Luglio 2026	N-PORT
ITOT · iShares Trust	0,00%	110.448 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,00%	23.393 SH	03 Settembre 2026	Giornaliero
DFUS · Dimensional ETF Trust	0,00%	10.048 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	553.375 SH	19 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	2.074.332 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	5.108 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,00%	140.406 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	564.368 SH	11 Settembre 2026	Giornaliero

FULC Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 11 analisti VENDI

Target mediano $4.00 +8,4%

0 0,0% Acquisto forte

0 0,0% Compra

7 63,6% Mantieni

2 18,2% Vendi

2 18,2% Vendita forte

Target Price a 12 Mesi

3 analisti · 2026-09-20

Target medio $3.67 -0,6%

Ora Prezzo attuale $3.69

Basso$3.00 Media$3.67 Alto$4.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
FULC	$753M	-9.6	2752.0%	·	-26.6%	·
BIOA	$495M	-5.9	·	-896.1%	-28.4%	·
EYPT	$1.51B	-5.8	-27.5%	-739.4%	-84.0%	·
SIGA	$438M	19.1	-31.8%	24.6%	11.4%	·
ANTX	$31M	-1.0	·	·	-57.7%	·
LLY	·	46.8	44.7%	31.7%	101.2%	·

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

FULC Fulcrum Therapeutics, Inc. - Common Stock